uniQure N.V. QURE
We included QURE in our premarket report on Thursday, after the company’s hemophilia gene therapy treatment was advanced to Phase III testing.
What followed was an enormous influx of volume, and two really solid, bullish sessions, advancing from a low of 11.55 on Thursday to a new high of 19.34 on Friday. That works out to a very respectable two-day swing of 67%
It’s the highest PPS QURE has attained since 2015, and the two sessions come in at numbers 1 and 2 highest volume days of all time, so we’d say our alert was timed with absolute precision.
Organovo Holdings, Inc. ONVO
We included ONVO in Friday morning’s extended watchlist, and it also put up a pretty good performance on the day.
From a low of 1.45, the stock traded as high as 1.80 on fairly heavy volume. We’ll want to see the stock continue to establish higher highs and higher lows as it’s coming off of its bottom.
PetMed Express, Inc. PETS
We’d like to signal a post-earnings options idea for PETS this morning, after the company set new records with its Q2 numbers. It’s gapping up significantly in the premarket, and the volume it traded on Friday leading into the release was the highest all month. We’re going to put the PETS 11/17 $40-50 Calls on watch moving forward.
TISA, IMNP, LBIX, GEVO, KALV, ATNM, ATOS, XNET
Incoming search terms:
- gene therapy atnm